Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dorothy Crowfoot Hodgkin made key contributions to Medical Sciences and was the third woman to win the Nobel Prize in Chemistry

Black and white photograph of Dorothy Crowfood Hodgkin

The New Biochemistry Building on South Parks Road has been renamed the Dorothy Crowfoot Hodgkin Building in honour of the third woman to win the Nobel Prize in Chemistry. Dorothy Crowfoot Hodgkin won the 1964 Nobel Prize in Chemistry for solving the atomic structure of molecules such as penicillin and insulin by using X-ray crystallography. The renaming of the building in Dorothy Crowfoot Hodgkin’s honour not only commemorates her ground-breaking research contributions to Medical Sciences; it also serves as a reminder of the vital research that takes place in the building today and celebrates her years-long association with the city of Oxford and the University.

The Dorothy Crowfoot Hodgkin Building is home to the Department of Biochemistry, the Kavli Institute for Nanoscience Discovery, the Oxford Genomics Centre, and a section of the Centre for Medicines Discovery.

Read the full story on the Department of Biochemistry website

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.